D., Zheng, Y., Wang, J
10.1111/NEP.13979 Summary Keywords safety, SGLT2 (sodium-glucose cotransporter 2) inhibitor, adverse drug (event), evidence medicine, review Citation Mascolo A, Di Napoli R, Balzano N, Cappetta D, Urbanek K, De Angelis A, Scisciola L, Di Meo I, Sullo MG, Rafaniello C and Sportiello L (2022) Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
Find a time that fits your routinewhether it's 7 AM before work or 9 AM after dropping the kids at schooland stick to it relentlessly
Your doctor will likely start you on a low dosage and adjust it over time to reach the right amount for you
Key takeaways Semaglutide, liraglutide, dulaglutide, and tirzepatide are GLP-1 medications that mimic hormones to control blood sugar and reduce weight
When both are active simultaneously, blood sugar can drop to dangerously low levels